Lotus Eye Hospital And Institute Ltd - 532998 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74 (5) of the SEBI (Depositories and Participants) Regulations 2018 ,For the quarter ended 31.03.2022 Lotus Eye Hospital And Institute Ltd - 532998 - Closure of Trading Window
This is to inform you that as per the SEBI (Prohibition of Insider trading ) regulations 2015 read with BSE Circular Ref No LIST/COMP/01/2019-20 and as per the terms of Code of Internal Procedures and conduct for regulating Monitoring and Reporting of Trading by Insider''s of the company, the trading window for dealing in the Company shares will remain closed from Friday, April 1, 2022 till the end of 48 hours after declaration of audited financial results for the year ending on 31st March 2022 for specified designated persons as defined in the code. The same has been informed to the Directors and designated persons of the Company. Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Dear Sir/Madam Sub: Resignation of Chief Financial Officer With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations Mr A Ganesh Chief Financial Officer has resigned from his office with effect from the closing hours of 25th March 2022. The Details as required under Regulation 30 of the Listing Regulation read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 09, 2015 is given in the enclosed Annexure I. This is for your information and record. Lotus Eye Hospital And Institute Ltd - 532998 - Communication To Holders Of Securities In Physical Mode
The Securities and Exchange Board of India has vide its Circular SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2021/655 dated November 3, 2021 read with clarificatory circular number SEBI/HO/MRSD/MIRSD_RTAMB/P/CIR/2021/687 dated December 14, 2021, introduced Common and Simplified Norms for processing investor's service request by RTAs and norms for furnishing PAN, KYC details and Nomination. In this regard, and in compliance with the above mentioned circulars, please find enclosed herewith the communication which has been sent to all shareholders/debenture holders holding shares / debentures of the Company in physical form indicating the process and documentation required for updating their KYC details, details of bank account, demat accounts, and nomination with RTA viz S.K.D.C Consultants Limited The Company has also uploaded the following Forms as stipulated in the Circulars on its website under the heading UPDATES FOR PHYSICAL SHAREHOLDERS: Lotus Eye Hospital And Institute Ltd - 532998 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed herewith the copy of Newspaper Advertisement published on February 16,2022 in Tamil Murasu (Coimbatore Edition) and Business Standard (All India Edition) in respect of financial results approved by the Board at its meeting held on February 14,2022.
Lotus Eye Hospital And Institute Ltd - 532998 - Appointment of Company Secretary and Compliance Officer
With reference to the captioned subject matter and pursuant to Regulation 30 (6) of the Listing Regulations read with Para A of Part A of Schedule III of the said regulations, we are delighted to inform that on recommendation of Nomination & Remuneration committee, the Board of Directors of the Company in its meeting held on Monday February 14th 2022 has appointed Mr M Achuth menon, holding membership number ACS 63980 as Company Secretary and Compliance officer of the company with effect from February 15th 2022. As per the provisions of Section 203 of the Companies Act 2013 read with relevant applicable rules Mr. M Achuth menon shall be a whole time key managerial personnel of the company. Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Outcome for Outcome Of Board Meeting Held On February 14Th 2022
Approved unaudited standalone results for the quarter and period ended December 31 2021 Lotus Eye Hospital And Institute Ltd - 532998 - Clarification Sought By BSE Due To Significant Movement In Share Price Of Lotus Eye Hospital And Institute Limited (Scrip Code: 532998) Dated February 02, 2022
This intimation shall be considered as reply to the clarification sought by Bombay Stock Exchange with reference to the significant movement in share price of Lotus Eye Hospital And Institute Limited dated February 02 2022. Lotus Eye Hospital And Institute Ltd - 532998 - Board Meeting Intimation for Consideration Of Financial Results
Lotus Eye Hospital And Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 ,inter alia, to consider and approve Unaudited Standalone financial results of the company for the quarter and the period ended December 31 2021.